June CÚRAM part of Irish Delegation at 18th National Conference on Health Economy in Germany
CÚRAM Scientific Director Professor Abhay Pandit part of the Irish delegation representing Ireland at the 18th National Conference on Health Economy which takes place in Rostock, Germany from today. Ireland has been selected as the partner country for this year’s event.
The two day conference (Wednesday and Thursday) will be attended by over 700 national and international experts from the health industry. A trade exhibition will also run alongside the conference which will increase the visibility and awareness of Ireland’s offering in the industry.
Professor Pandit will speak on the “Best Practice Partner Country Ireland” panel to highlight CURAM’s involvement in the Irish ecosystem and its EU programs as well as key industry collaborations.
Prof Pandit will also take part in the panel discussion on "Strengthening Strategic Autonomy in the Industrial Healthcare Industry" which will explore the topic of R & D funding and life science location funding in Ireland.
Minister of State for Business, Employment and Retail, Neale Richmond, will be in attendance.
Minister Richmond said: "I am delighted to attend this event as Ireland’s representative and meet with senior leaders across industry and Government to further strengthen our excellent relationship with Germany.”
"Ireland’s reputation as a global location of excellence in medtech and next-gen biopharma products is a result of our continued investment in innovation. Investing in leading-edge healthcare and health technology drives economic performance, but more importantly it helps us to discover new innovations which can improve healthcare standards for our citizens, allowing people to live longer, healthier lives with more independence."
Ireland is partner country to the conference this year, which presents a valuable opportunity to strengthen the development of the healthcare industry and to foster the relationship between Ireland and Germany.
Since 2005, the conference has developed into one of the health industry’s most important annual meeting points, providing a platform for establishing and intensifying contacts between key industry representatives.
The programme will include presentations from Ireland’s enterprise agencies, Enterprise Ireland and IDA Ireland, along will panel discussions with representatives from Science Foundation Ireland, the Tyndall National Institute, and the Health Innovation Hub Ireland.
The life sciences sector in Ireland contributes significantly to our economy, accounting for over €100 billion in exports and employing over 80,000 people in Ireland in activities ranging from manufacturing, R&D, supply chain and a variety of EMEA and global services.
Germany is an important export market for Ireland’s medical and pharmaceutical products with our trading relationship growing all the time. In 2021, the total value of Ireland's trade with Germany was valued at €53 billion which marks a 155% increase in the 10 years since 2011.
About CÚRAM
CÚRAM, Ireland’s National Medical Device Research and Development Centre, has established itself as a global leader in the field, with committed funding of over €270 million. The primary objective of CÚRAM is to enhance the quality of life for individuals afflicted with chronic illnesses. To achieve this, the Centre's scientific program addresses significant issues, technical hurdles, and the existing limitations pertaining to medical device design and functionalization. CÚRAM's core focus revolves around the enhancement of existing devices, the development of convergent technologies for clinical solutions, and the facilitation of clinical translation.
The Centre excels in its capacity to bring together specialized researchers, industry partners, and clinicians, thereby fostering collaborative networks that aim to develop solutions for global health challenges. CÚRAM's researchers concentrate on engineering strategies for repair and remodelling, advancements in drug delivery solutions, and the design of superior and smart medical implants to treat chronic diseases effectively. These diseases encompass a broad spectrum of conditions, including chronic and acute respiratory ailments, cardiovascular disease (CVD), diabetes, neurodegenerative and musculoskeletal conditions.
With the intention of fostering fruitful collaborations, CÚRAM seeks to utilize this event as a platform to introduce and engage with policy, academic and industry partners from Germany. The primary objective is to explore collaborative opportunities for the creation and translation of medical devices that are ready for clinical implementation and prioritize the needs of patients. By forging partnerships with German entities, CÚRAM aims to leverage the collective expertise and resources of both nations to develop innovative medical solutions that can directly benefit individuals in need.